March 1, 2021 | In commemoration of the 50th Anniversary of the National Cancer Act, the Division of Cancer Prevention honors Christine Miaskowski, RN, PhD, FAAN, as a champion and changemaker of cancer prevention, early detection and symptom science.
February 17, 2021 | Women in academic medicine are facing the prospect of career setbacks as a result of the COVID-19 pandemic. A recently published Viewpoint article in JAMA Oncology by UCSF physician-scientists addressed the issue and offered solutions for institutions.
February 12, 2021 | Many cancer patients might respond better to treatments with the help of a new prognostic indicator based on a distinctive pattern of gene activity within tumor cells, according to a new study of human cancer data and experiments on human cancer cell lines grown in the lab.
February 11, 2021 | Source: UCSF.edu. A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
Jan 25, 2021. Scientists at UC San Francisco’s Quantitative Bioscience Institute (QBI) and the Icahn School of Medicine at Mt. Sinai (ISMMS) in New York have shown that plitidepsin (Aplidin), a drug approved by the Australian Regulatory Agency for the treatment of multiple myeloma, has potent antiviral activity against SARS-CoV-2, the virus that causes COVID-19.
Jan 14, 2021 Over the past 15 years, the cancer center’s Community Advisory Board (CAB) has become one of UCSF’s most instrumental community outreach groups for improving health equity. In a Q&A, CAB Chair Arnold Perkins and Dr. Kim Rhoads discuss why CABs are critical to the work of NCI cancer centers and the communities they serve.